What are the major opportunities in the Asthma Therapeutics market? What are the strategies for the Asthma Therapeutics market?

For detailed insights on the major opportunities and strategies in the Asthma Therapeutics market, Read More

How does the Asthma Therapeutics market relate to the overall economy and other similar markets?

For detailed insights on Asthma Therapeutics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Asthma Therapeutics market growth? SWOT analysis of the Asthma Therapeutics market.

For detailed insights on the key dynamics influencing the Asthma Therapeutics market growth and SWOT analysis of the Asthma Therapeutics industry, Read More

Global Asthma Therapeutics Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages : 250

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Asthma Therapeutics Global Market Report 2025

Name: Asthma Therapeutics Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Drug Class (Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhalers (ICS + LABA)), By Treatment Stage (Acute Treatment, Long-Term Control, Preventive Treatment, Maintenance Regimens, Rescue Medications), By Route Of administration (Oral, Inhaled, Intravenous, Subcutaneous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Homecare, Specialty Clinics) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Asthma Therapeutics Market Overview

• Asthma Therapeutics market size has reached to $30.63 billion in 2024

• Expected to grow to $44.53 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%

• Growth Driver: Increasing Prevalence Of Asthma Fueling The Growth Of The Market Due To Rising Exposure To Air Pollution And Associated Health Risks

• Market Trend: Product Innovation In Fixed-Dose Combination (FDC) Drugs Fuels The Market Growth Due To Enhanced Treatment Efficacy And Improved Patient Adherence

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Asthma Therapeutics Market?

Asthma therapeutics refers to the range of medications and treatments used to manage and relieve asthma symptoms, a chronic respiratory condition characterized by airway inflammation and constriction. These therapies include quick-relief medications for immediate symptom control and long-term control drugs that help reduce airway inflammation and prevent asthma attacks.

The main types of drug classes included in asthma therapeutics are inhaled corticosteroids (ICS), long-acting beta agonists, leukotriene receptor antagonists, short-acting beta agonists, biologics, and combination inhalers. Inhaled corticosteroids are medicines breathed directly into the lungs to reduce inflammation and swelling in the airways, making it easier to breathe for people with asthma. They are used at different treatment stages, such as acute treatment, long-term control, preventive treatment, maintenance regimens, and rescue medications, by various routes of administration, including oral, inhaled, intravenous, and subcutaneous. They are different distribution channels, such as hospital pharmacies, retail pharmacies, and online pharmacies, and are used by several end-users, including hospitals, home care, and specialty clinics.

Asthma Therapeutics Market Size and growth rate 2025 to 2029: Graph

What Is The Asthma Therapeutics Market Size 2025 And Growth Rate?

The asthma therapeutics market size has grown strongly in recent years. It will grow from $30.63 billion in 2024 to $33.11 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising awareness about asthma management, increasing adoption of inhalers and nebulizers, growing prevalence of allergic asthma due to pollution, rising government initiatives for respiratory health, and growing healthcare infrastructure in emerging economies.

What Is The Asthma Therapeutics Market Growth Forecast?

The asthma therapeutics market size is expected to see strong growth in the next few years. It will grow to $44.53 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to rising demand for biologics in asthma treatment, increasing focus on personalized medicine, growing use of digital inhalers and smart health devices, rising prevalence of pediatric asthma, and increasing investment in research and development for novel therapeutics. Major trends in the forecast period include advancement in biologic therapies for severe asthma, advanced inhaler technologies with digital tracking, development of personalized asthma treatment plans, innovation in drug-delivery mechanisms, and integration of artificial intelligence and wearable devices for asthma monitoring.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Asthma Therapeutics Market Segmented?

1) By Drug Class: Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhalers (ICS + LABA)

2) By Treatment Stage: Acute Treatment, Long-Term Control, Preventive Treatment, Maintenance Regimens, Rescue Medications

3) By Route Of administration: Oral, Inhaled, Intravenous, Subcutaneous

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Homecare, Specialty Clinics

Subsegments:

1) By Inhaled Corticosteroids (ICS): Fluticasone, Budesonide, Beclomethasone, Mometasone, Ciclesonide

2) By Long-Acting Beta Agonists (LABA): Salmeterol, Formoterol, Indacaterol, Olodaterol

3) By Leukotriene Receptor Antagonists (LTRA): Montelukast, Zafirlukast, Pranlukast

4) By Short-Acting Beta Agonists (SABA): Albuterol (Salbutamol), Levalbuterol, Terbutaline

5) By Biologics: Omalizumab, Mepolizumab, Benralizumab, Dupilumab, Reslizumab

6) By Combination Inhalers (ICS + LABA): Fluticasone + Salmeterol, Budesonide + Formoterol, Mometasone + Indacaterol, Beclomethasone + Formoterol

What Is Driving The Asthma Therapeutics Market? Increasing Prevalence Of Asthma Fueling The Growth Of The Market Due To Rising Exposure To Air Pollution And Associated Health Risks

The increasing prevalence of asthma is expected to propel the growth of the asthma therapeutics market going forward. Asthma refers to a long-term disease that causes inflammation and swelling of the airways, resulting in the narrowing of the airways that carry air from the nose and mouth to the lungs. The increasing prevalence of asthma is due to increasing pollutants, which irritate the airways and raise the risk of developing the condition. Asthma therapeutics help manage asthma by controlling airway inflammation, relieving symptoms, and preventing asthma attacks. Long-term control medications like inhaled corticosteroids reduce chronic inflammation, while quick-relief drugs such as bronchodilators provide immediate relief during flare-ups. For instance, in April 2024, according to Asthma + Lung UK, an England-based charity that supports people with lung conditions, the number of asthma-related deaths in England increased from 1,146 in 2021 to 1,236 in 2022. Therefore, the increasing prevalence of asthma is driving the growth of the asthma therapeutics industry.

Who Are The Major Players In The Global Asthma Therapeutics Market?

Major companies operating in the asthma therapeutics market are Roche Holding AG, Merck & Co Inc., Pfizer Inc., AstraZeneca plc, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Vertex Pharmaceuticals Incorporated, Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mundipharma International Limited, ALK-Abello, Mylan N.V., Whanin Pharmaceutical, Mitsubishi Tanabe Pharma, Allergan plc.

What Are The Key Trends Of The Global Asthma Therapeutics Market? Product Innovation In Fixed-Dose Combination (FDC) Drugs Fuels The Market Growth Due To Enhanced Treatment Efficacy And Improved Patient Adherence

Major companies operating in the asthma therapeutics market are focusing on developing innovative products, such as fixed-dose combination (FDC) drugs, to enhance treatment efficacy and improve patient adherence. A fixed-dose combination (FDC) drug is a medication that contains two or more active pharmaceutical ingredients combined in a single dosage form, such as a tablet or inhaler, intended to treat a specific condition. For instance, in June 2022, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company, launched a novel fixed-dose combination (FDC) drug, Indacaterol plus Mometasone, to treat asthma. Indacaterol is a long-acting beta-agonist (LABA) that helps relax airway muscles, while Mometasone is an inhaled corticosteroid (ICS) that reduces lung inflammation. This FDC is designed to offer improved symptom control and convenience through once-daily dosing, enhancing treatment adherence among moderate to severe asthma patients.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Asthma Therapeutics Market? Sandoz Expands Respiratory Portfolio with Acquisition of Inhaler Specialist Coalesce

In March 2022, Sandoz Group AG, a Switzerland-based pharmaceutical company, acquired Coalesce Product Development Limited for an undisclosed amount. With this acquisition, Sandoz aimed to strengthen its respiratory and complex generics capabilities by enhancing its development of inhalation drug-delivery devices, supporting growth in asthma and other respiratory therapeutic areas. Coalesce Product Development Limited is a UK-based company that designs and develops medical and drug delivery devices for the respiratory market, including asthma.

What Is The Regional Outlook For The Global Asthma Therapeutics Market?

North America was the largest region in the acute care telemedicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acute Care Telemedicine Market?

The acute care telemedicine market includes revenues earned by entities by providing services like virtual emergency care, remote intensive care unit monitoring, tele-stroke evaluations, virtual hospitalist support, and real-time specialist consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Asthma Therapeutics Industry?

The asthma therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including asthma therapeutics industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the asthma therapeutics industry. The asthma therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Asthma Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$33.11 billion
Revenue Forecast In 2034	$44.53 billion
Growth Rate	CAGR of 7.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Drug Class, Treatment Stage, Route Of administration, Distribution Channel, End-User, Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhal
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Roche Holding AG, Merck & Co Inc., Pfizer Inc., AstraZeneca plc, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Vertex Pharmaceuticals Incorporated, Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mundipharma International Limited, ALK-Abello, Mylan N.V., Whanin Pharmaceutical, Mitsubishi Tanabe Pharma, Allergan plc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Asthma Therapeutics Market Characteristics

3. Asthma Therapeutics Market Trends And Strategies

4. Asthma Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Asthma Therapeutics Growth Analysis And Strategic Analysis Framework

5.1. Global Asthma Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Asthma Therapeutics Market Growth Rate Analysis

5.4. Global Asthma Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Asthma Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Asthma Therapeutics Total Addressable Market (TAM)

6. Asthma Therapeutics Market Segmentation

6.1. Global Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inhaled Corticosteroids (ICS)

Long-Acting Beta Agonists (LABA)

Leukotriene Receptor Antagonists (LTRA)

Short-Acting Beta Agonists (SABA)

Biologics

Combination Inhalers (ICS + LABA)

6.2. Global Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acute Treatment

Long-Term Control

Preventive Treatment

Maintenance Regimens

Rescue Medications

6.3. Global Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Inhaled

Intravenous

Subcutaneous

6.4. Global Asthma Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

6.5. Global Asthma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Homecare

Specialty Clinics

6.6. Global Asthma Therapeutics Market, Sub-Segmentation Of Inhaled Corticosteroids (ICS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Fluticasone

Budesonide

Beclomethasone

Mometasone

Ciclesonide

6.7. Global Asthma Therapeutics Market, Sub-Segmentation Of Long-Acting Beta Agonists (LABA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Salmeterol

Formoterol

Indacaterol

Olodaterol

6.8. Global Asthma Therapeutics Market, Sub-Segmentation Of Leukotriene Receptor Antagonists (LTRA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Montelukast

Zafirlukast

Pranlukast

6.9. Global Asthma Therapeutics Market, Sub-Segmentation Of Short-Acting Beta Agonists (SABA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Albuterol (Salbutamol)

Levalbuterol

Terbutaline

6.10. Global Asthma Therapeutics Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Omalizumab

Mepolizumab

Benralizumab

Dupilumab

Reslizumab

6.11. Global Asthma Therapeutics Market, Sub-Segmentation Of Combination Inhalers (ICS + LABA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Fluticasone + Salmeterol

Budesonide + Formoterol

Mometasone + Indacaterol

Beclomethasone + Formoterol

7. Asthma Therapeutics Market Regional And Country Analysis

7.1. Global Asthma Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Asthma Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Asthma Therapeutics Market

8.1. Asia-Pacific Asthma Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Asthma Therapeutics Market

9.1. China Asthma Therapeutics Market Overview

9.2. China Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Asthma Therapeutics Market

10.1. India Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Asthma Therapeutics Market

11.1. Japan Asthma Therapeutics Market Overview

11.2. Japan Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Asthma Therapeutics Market

12.1. Australia Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Asthma Therapeutics Market

13.1. Indonesia Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Asthma Therapeutics Market

14.1. South Korea Asthma Therapeutics Market Overview

14.2. South Korea Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Asthma Therapeutics Market

15.1. Western Europe Asthma Therapeutics Market Overview

15.2. Western Europe Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Asthma Therapeutics Market

16.1. UK Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Asthma Therapeutics Market

17.1. Germany Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Asthma Therapeutics Market

18.1. France Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Asthma Therapeutics Market

19.1. Italy Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Asthma Therapeutics Market

20.1. Spain Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Asthma Therapeutics Market

21.1. Eastern Europe Asthma Therapeutics Market Overview

21.2. Eastern Europe Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Asthma Therapeutics Market

22.1. Russia Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Asthma Therapeutics Market

23.1. North America Asthma Therapeutics Market Overview

23.2. North America Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Asthma Therapeutics Market

24.1. USA Asthma Therapeutics Market Overview

24.2. USA Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Asthma Therapeutics Market

25.1. Canada Asthma Therapeutics Market Overview

25.2. Canada Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Asthma Therapeutics Market

26.1. South America Asthma Therapeutics Market Overview

26.2. South America Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Asthma Therapeutics Market

27.1. Brazil Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Asthma Therapeutics Market

28.1. Middle East Asthma Therapeutics Market Overview

28.2. Middle East Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Asthma Therapeutics Market

29.1. Africa Asthma Therapeutics Market Overview

29.2. Africa Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Asthma Therapeutics Market Competitive Landscape And Company Profiles

30.1. Asthma Therapeutics Market Competitive Landscape

30.2. Asthma Therapeutics Market Company Profiles

30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Asthma Therapeutics Market Other Major And Innovative Companies

31.1. Novartis AG

31.2. GlaxoSmithKline plc

31.3. Takeda Pharmaceutical Company Limited

31.4. Amgen Inc.

31.5. Boehringer Ingelheim GmbH

31.6. Teva Pharmaceutical Industries Ltd.

31.7. Regeneron Pharmaceuticals Inc.

31.8. Astellas Pharma Inc.

31.9. Vertex Pharmaceuticals Incorporated

31.10. Sun Pharmaceutical Industries Ltd.

31.11. Chiesi Farmaceutici S.p.A.

31.12. Cipla Limited

31.13. Mundipharma International Limited

31.14. ALK-Abello

31.15. Mylan N.V.

32. Global Asthma Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Asthma Therapeutics Market

34. Recent Developments In The Asthma Therapeutics Market

35. Asthma Therapeutics Market High Potential Countries, Segments and Strategies

35.1 Asthma Therapeutics Market In 2029 - Countries Offering Most New Opportunities

35.2 Asthma Therapeutics Market In 2029 - Segments Offering Most New Opportunities

35.3 Asthma Therapeutics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Asthma Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Asthma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Asthma Therapeutics Market, Sub-Segmentation Of Inhaled Corticosteroids (ICS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Asthma Therapeutics Market, Sub-Segmentation Of Long-Acting Beta Agonists (LABA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Asthma Therapeutics Market, Sub-Segmentation Of Leukotriene Receptor Antagonists (LTRA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Asthma Therapeutics Market, Sub-Segmentation Of Short-Acting Beta Agonists (SABA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Asthma Therapeutics Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Asthma Therapeutics Market, Sub-Segmentation Of Combination Inhalers (ICS + LABA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Global Asthma Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Global Asthma Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Asia-Pacific, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Asia-Pacific, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: China, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: China, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: India, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: India, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Japan, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Japan, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Australia, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Australia, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Indonesia, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Indonesia, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: South Korea, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: South Korea, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Western Europe, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Western Europe, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: UK, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: UK, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Germany, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Germany, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: France, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: France, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Italy, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Italy, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Spain, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Spain, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Eastern Europe, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Eastern Europe, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Russia, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: Russia, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: North America, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: North America, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: USA, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: USA, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Canada, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Canada, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: South America, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: South America, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Brazil, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Brazil, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Middle East, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Middle East, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Africa, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 81: Africa, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 82: Roche Holding AG Financial Performance

Table 83: Merck & Co Inc. Financial Performance

Table 84: Pfizer Inc. Financial Performance

Table 85: AstraZeneca plc Financial Performance

Table 86: Sanofi S.A. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Asthma Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Asthma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Asthma Therapeutics Market, Sub-Segmentation Of Inhaled Corticosteroids (ICS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Asthma Therapeutics Market, Sub-Segmentation Of Long-Acting Beta Agonists (LABA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Asthma Therapeutics Market, Sub-Segmentation Of Leukotriene Receptor Antagonists (LTRA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Asthma Therapeutics Market, Sub-Segmentation Of Short-Acting Beta Agonists (SABA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Asthma Therapeutics Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Asthma Therapeutics Market, Sub-Segmentation Of Combination Inhalers (ICS + LABA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Global Asthma Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Global Asthma Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Asia-Pacific, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Asia-Pacific, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: China, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: China, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: India, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: India, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Japan, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Japan, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Australia, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Australia, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Indonesia, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Indonesia, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: South Korea, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: South Korea, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Western Europe, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Western Europe, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: UK, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: UK, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Germany, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Germany, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: France, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: France, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Italy, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Italy, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Spain, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Spain, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Eastern Europe, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Eastern Europe, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Russia, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: Russia, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: North America, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: North America, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: USA, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: USA, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Canada, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Canada, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: South America, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: South America, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Brazil, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Brazil, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Middle East, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Middle East, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Asthma Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Africa, Asthma Therapeutics Market, Segmentation By Treatment Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 81: Africa, Asthma Therapeutics Market, Segmentation By Route Of administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 82: Roche Holding AG Financial Performance

Figure 83: Merck & Co Inc. Financial Performance

Figure 84: Pfizer Inc. Financial Performance

Figure 85: AstraZeneca plc Financial Performance

Figure 86: Sanofi S.A. Financial Performance

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Allergic Rhinitis Drugs Global Market Report 2025 – By Disease (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), By Treatment (Antihistamines, Immunotherapy, Corticosteroids, Deco...

Lower Respiratory Tract Therapeutics Global Market Report 2025 – By Disease Type (Asthma, Chronic obstructive pulmonary disease, Pneumonia, Tuberculosis, Bronchitis, Other Diseases), By Drug Class (Antibiotics, Non-Stero...

Anti-Asthmatic And COPD Drugs Market 2021 - By Drug Class (Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs), By End User (Asthma Patients, COPD Patients), By Distribution Channel (Gener...

Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Global Market Report 2025 – By Type (Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types), B...

Asthma Drugs Global Market Report 2025 – By Type Of Asthma (Allergic, Non-Allergic), By Asthma Trigger Type (Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Noc...

Asthma Spacers Global Market Report 2025 – By Product (Aerochamber, Optichamber, Volumatic, Inspirease, Other Products), By Distribution Channels (E-commerce Channels, Retail Pharmacies, Hospital Pharmacies, Other Distri...

Anti-Asthmatic And COPD Drugs Market 2021 - By Drug Class (Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs), By End User (Asthma Patients, COPD Patients), By Distribution Channel (Gener...

Frequently Asked Questions

What is the definition of the Asthma Therapeutics market?

How will the Asthma Therapeutics market drivers and restraints affect the market dynamics? What forces will shape the Asthma Therapeutics industry going forward?

The Asthma Therapeutics market major growth driver - Increasing Prevalence Of Asthma Fueling The Growth Of The Market Due To Rising Exposure To Air Pollution And Associated Health Risks. For further insights on the Asthma Therapeutics market, request a sample here

What is the forecast market size or the forecast market value of the Asthma Therapeutics market?

The Asthma Therapeutics market size has grown strongly in recent years. The asthma therapeutics market size has grown strongly in recent years. It will grow from $30.63 billion in 2024 to $33.11 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising awareness about asthma management, increasing adoption of inhalers and nebulizers, growing prevalence of allergic asthma due to pollution, rising government initiatives for respiratory health, and growing healthcare infrastructure in emerging economies. The asthma therapeutics market size is expected to see strong growth in the next few years. It will grow to $44.53 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to rising demand for biologics in asthma treatment, increasing focus on personalized medicine, growing use of digital inhalers and smart health devices, rising prevalence of pediatric asthma, and increasing investment in research and development for novel therapeutics. Major trends in the forecast period include advancement in biologic therapies for severe asthma, advanced inhaler technologies with digital tracking, development of personalized asthma treatment plans, innovation in drug-delivery mechanisms, and integration of artificial intelligence and wearable devices for asthma monitoring. For further insights on the Asthma Therapeutics market, request a sample here

How is the Asthma Therapeutics market segmented?

The asthma therapeutics market covered in this report is segmented –
1) By Drug Class: Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhalers (ICS + LABA)
2) By Treatment Stage: Acute Treatment, Long-Term Control, Preventive Treatment, Maintenance Regimens, Rescue Medications
3) By Route Of administration: Oral, Inhaled, Intravenous, Subcutaneous
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End-User: Hospitals, Homecare, Specialty Clinics Subsegments:
1) By Inhaled Corticosteroids (ICS): Fluticasone, Budesonide, Beclomethasone, Mometasone, Ciclesonide
2) By Long-Acting Beta Agonists (LABA): Salmeterol, Formoterol, Indacaterol, Olodaterol
3) By Leukotriene Receptor Antagonists (LTRA): Montelukast, Zafirlukast, Pranlukast
4) By Short-Acting Beta Agonists (SABA): Albuterol (Salbutamol), Levalbuterol, Terbutaline
5) By Biologics: Omalizumab, Mepolizumab, Benralizumab, Dupilumab, Reslizumab
6) By Combination Inhalers (ICS + LABA): Fluticasone + Salmeterol, Budesonide + Formoterol, Mometasone + Indacaterol, Beclomethasone + Formoterol For further insights on the Asthma Therapeutics market, request a sample here

Which region has the largest share of the Asthma Therapeutics market? What are the other regions covered in the report?

North America was the largest region in the asthma therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Asthma Therapeutics market, request a sample here.

Who are the major players in the Asthma Therapeutics market?

What are the key trends in the Asthma Therapeutics market?

Major trends in the Asthma Therapeutics market include Product Innovation In Fixed-Dose Combination (FDC) Drugs Fuels The Market Growth Due To Enhanced Treatment Efficacy And Improved Patient Adherence. For further insights on the Asthma Therapeutics market, request a sample here.